23 October 2006

The Prescription Medicines Code of Practice Authority (PMCPA) has today welcomed the launch of revised guidance for doctors from the General Medical Council (GMC) which focuses, in part, on the need for doctors to declare conflicts of interest and not accept any inducement, gift or hospitality that may influence, or be seen to influence prescribing.

2 October 2006 

Merck Sharp & Dohme (MSD) Ltd has been suspended from membership of the Association of the British Pharmaceutical Industry (ABPI) for a minimum of three months in connection with serious breaches of the ABPI Code of Practice, it was announced today

22 September 2006

Merck Sharp & Dohme is the subject of an admonishment through advertisements in the medical and pharmaceutical press which highlight breaches of The Association of the British Pharmaceutical Industry’s (ABPI) Code of Practice for the Pharmaceutical Industry.

Date advertisments appeared: 22 September 2006

For entertaining health professionals and their spouses at a meeting with no clear educational content in an unsuitable venue, Merck Sharp & Dohme was ruled in breach of the Code

20 September 2006

The Prescription Medicine Code of Practice Authority (PMCPA) has boosted its capacity to improve awareness of the recently revised ABPI Code of Practice for the Pharmaceutical Industry by appointing a new communications manager.

16 November 2005

Details of the revised and updated ABPI Code of Practice that governs the UK-based pharmaceutical industry's relations with healthcare professionals and other stakeholders were published today. The new code comes into effect on January 1, 2006.